| 标题 |
A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | INTERVENTION: DRV/c group:DRV/c (800mg/150mg QD) + Conventional treatment containing thymosin (1.6 mg SC QOD) ;LPV/r group:LPV/r (400mg/100mg bid) + Conventional treatment containing thymosin (1.6 mg SC QOD);other group:Conventional treatment containing thymosin (1.6 mg SC QOD) ; CONDITION: novel coronavirus pneumonia (COVID‐19) PRIMARY OUTCOME: Time to conversion of 2019‐nCoV RNA result from RI sample; SECONDARY OUTCOME: all cause mortality;Time to temperature |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
愉快的真
神勇映雁
Lifeismovie
嘻嘻哈哈
学霸业
Criminology34
GingerF
如意的歌曲
guangzhui
Banff
DW
herococa
逍遥
OK
jonwick1
林狗
loii
典雅夏之
leah
sutharsons
皖公网安备34019202002308
